Earnings

Following a challenging period for its share price, Nutanix enters a critical phase. The company is intensifying its focus on...

Investor attention is firmly fixed on Sangamo Therapeutics as the company approaches several pivotal near-term events. The dual catalysts of...

The European automotive sector's earnings season is gaining momentum, placing Porsche Automobil Holding SE squarely under the market's microscope. As...

This week, Viking Therapeutics' management is engaging directly with institutional investors at two separate events in Miami. The central topic...

UnitedHealth Group finds itself at a pivotal juncture, balancing shareholder returns with strategic flexibility as it undertakes a significant operational...

Investors in Australian financial services provider Plenti Ltd are focusing on two key timelines: the upcoming annual results in May...

Centuria Metropolitan REIT has released its quarterly distribution details alongside financial results for the first half of the 2026 fiscal...

Bitcoin Well has released its financial results for the 2025 fiscal year, showcasing a period of substantial top-line expansion and...

As Avante approaches the conclusion of its fiscal year on March 31, 2026, the company's strategic evolution is under scrutiny....

For investors monitoring Bravern Ventures, the company's immediate trajectory is defined by two parallel tracks: navigating standard regulatory milestones and...